fig1

Overcoming immuno-resistance by rescheduling anti-VEGF/cytotoxics/anti-PD-1 combination in lung cancer model

Figure 1. Summary of the experimental designs, (A) 1st immunomodulatory experiment; and (B) 2nd comparative efficacy experiment including anti-PD-1 treatment.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/